Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,317,653 papers from all fields of science
Search
Sign In
Create Free Account
ULBP1 gene
Known as:
ULBP1
, MULT1
, UL16-BINDING PROTEIN 1
Expand
This gene is involved in the function of natural killer cells.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
ULBP1 protein, human
Narrower (1)
ULBP1 wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors
I. Veneziani
,
D. Fruci
,
M. Compagnone
,
V. Pistoia
,
P. Rossi
,
L. Cifaldi
OncoTarget
2019
Corpus ID: 87521240
Low expression of ligands for NK cell-activating receptors contributes to neuroblastoma (NB) aggressiveness. Recently, we…
Expand
2016
2016
Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity
Yoav Bauman
,
N. Drayman
,
+5 authors
O. Mandelboim
OncoTarget
2016
Corpus ID: 17133098
Polyomaviruses are a diverse family of viruses which are prevalent in the human population. However, the interactions of these…
Expand
2015
2015
Sub-apoptotic dosages of pro-oxidant vitamin cocktails sensitize human melanoma cells to NK cell lysis
Elisa Tremante
,
L. Santarelli
,
+5 authors
P. Giacomini
OncoTarget
2015
Corpus ID: 2331340
Alpha-tochopheryl succinate (αTOS), vitamin K3 (VK3) and vitamin C (ascorbic acid, AA) were previously shown to synergistically…
Expand
2014
2014
Microenvironment and Immunology RAE 1 Ligands for the NKG 2 D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
A. R. Lam
,
N. L. Bert
,
+8 authors
D. Raulet
2014
Corpus ID: 27714128
The immunoreceptor NKG2D originally identified in natural killer (NK) cells recognizes ligands that are upregulated on tumor…
Expand
2011
2011
Role of NKG2D and its ligands in the anti‐infectious activity of Vγ9Vδ2 T cells against intracellular bacteria
Stéphanie Bessoles
,
M. Ni
,
S. García-Jiménez
,
Françoise Sanchez
,
V. Lafont
European Journal of Immunology
2011
Corpus ID: 38308602
Human Vγ9Vδ2 T cells play a crucial role in early immune response to intracellular pathogens. Their number is drastically…
Expand
2011
2011
Cutting Edge: NKG2D-Dependent Cytotoxicity Is Controlled by Ligand Distribution in the Target Cell Membrane
Emily M. Martinez
,
Joseph A. Brzostowski
,
Eric O Long
,
C. Gross
Journal of Immunology
2011
Corpus ID: 1602905
Although the importance of membrane microdomains in receptor-mediated activation of lymphocytes has been established, much less…
Expand
2010
2010
The MHC class Ib protein ULBP 1 is a nonredundant determinant of leukemia / lymphoma susceptibility to T-cell cytotoxicity
T. Lança
,
D. V. Correia
,
+8 authors
B. Silva-Santos
2010
Corpus ID: 33503661
On the path to successful immunotherapy of hematopoietic tumors, T cells offer great promise because of their human leukocyte…
Expand
Highly Cited
2007
Highly Cited
2007
Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection.
T. Ebihara
,
H. Masuda
,
+5 authors
T. Seya
International Immunology
2007
Corpus ID: 16590063
Monocyte-derived dendritic cells (mDCs) and NK cells are reciprocally activate via cytokines and cell-cell contact. Although…
Expand
2006
2006
TGF-b and metalloproteinases differentially suppress NKG 2 D ligand surface expression on malignant glioma cells
G. Eisele
,
J. Wischhusen
,
+5 authors
M. Friese
2006
Corpus ID: 14686583
NKG2D ligands (NKG2DL) are expressed by infected and transformed cells. They transmit danger signals to NKG2D-expressing immune…
Expand
Highly Cited
2002
Highly Cited
2002
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia…
S. Farag
,
S. George
,
+10 authors
M. Caligiuri
Clinical Cancer Research
2002
Corpus ID: 18221897
PURPOSE The purpose of the study is to investigate the tolerability of interleukin 2 (IL-2) after intensive chemotherapy in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE